Neurology AssociatesJul 25, 20233 min readNeurologist Offers Perspective on Lequembi, Alzheimer’s Drug Newly Approved by FDANeurology Associates' Dr. Andrea An discusses the significance of the FDA's new approval for the Alzheimer's drug Lequembi.
Neurology AssociatesMar 13, 20231 min readLong COVID Now Seen as Neurological ConditionFor most people, the worst of COVID-19 has passed. But did you know that long COVID continues to impact about 16 million U.S. adults? And...
Neurology AssociatesFeb 24, 20231 min readNeurologist FAQ #5: Do Neurologists Treat Depression?Recent statistics indicate that almost one-quarter of U.S. adults felt depressed within the last two weeks. That’s a significant number...
Neurology AssociatesFeb 24, 20232 min readNeurologist FAQ #4: How Do I Choose the Right Neurologist for Me?Given the conditions and symptoms outlined in the previous blogs in our series, “FAQs About Neurology and Neurologists,” knowing how to...
Kelly TealJan 27, 20232 min readRecent Research Shows Promise for New Parkinson’s-Symptoms DrugsResearchers at Oregon Health & Science University have made a big discovery regarding Parkinson's.
Kelly TealJan 18, 20232 min readLecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With CautionNeurology Associates Neuroscience Center looks at the side effects of lecanemab, the newly FDA-approved drug for Alzheimer's.
Kelly TealDec 21, 20224 min readMeet the Neurology Experts We Added in 2022Neurology Associates brought on six new experts -- two neurologists, two physician assistants, and two nurse practitioners -- in 2022.